Crescent Capital BDC (CCAP) Projected to Post Quarterly Earnings on Wednesday

Crescent Capital BDC (NASDAQ:CCAP) is projected to issue its Q4 2025 results after the market closes on Wednesday, February 25th. Analysts expect the company to announce earnings of $0.44 per share and revenue of $39.83 million for the quarter. Individuals may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Thursday, February 26, 2026 at 12:00 PM ET.

Crescent Capital BDC Stock Down 2.6%

Shares of NASDAQ CCAP opened at $12.96 on Tuesday. The stock has a market cap of $479.39 million, a P/E ratio of 13.22 and a beta of 0.55. The business’s fifty day simple moving average is $14.33 and its 200-day simple moving average is $14.54. Crescent Capital BDC has a 12-month low of $12.95 and a 12-month high of $18.57. The company has a current ratio of 1.20, a quick ratio of 1.20 and a debt-to-equity ratio of 1.23.

Analysts Set New Price Targets

CCAP has been the topic of a number of analyst reports. Keefe, Bruyette & Woods reduced their price target on Crescent Capital BDC from $17.00 to $15.50 and set an “outperform” rating on the stock in a research report on Friday, November 14th. Zacks Research raised shares of Crescent Capital BDC from a “strong sell” rating to a “hold” rating in a report on Tuesday, February 10th. Wells Fargo & Company decreased their price target on shares of Crescent Capital BDC from $15.00 to $14.00 and set an “equal weight” rating for the company in a research note on Friday, November 14th. Oppenheimer dropped their price objective on shares of Crescent Capital BDC from $20.00 to $19.00 and set an “outperform” rating on the stock in a research report on Friday, November 14th. Finally, Wall Street Zen upgraded shares of Crescent Capital BDC from a “sell” rating to a “hold” rating in a report on Saturday, January 10th. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $16.38.

Institutional Trading of Crescent Capital BDC

Several institutional investors have recently modified their holdings of CCAP. Northwestern Mutual Wealth Management Co. acquired a new position in shares of Crescent Capital BDC in the 4th quarter valued at $27,000. VPR Management LLC lifted its position in Crescent Capital BDC by 150.0% in the third quarter. VPR Management LLC now owns 5,000 shares of the company’s stock valued at $71,000 after acquiring an additional 3,000 shares during the last quarter. Permanens Capital L.P. acquired a new position in Crescent Capital BDC in the third quarter valued at $147,000. XTX Topco Ltd purchased a new position in shares of Crescent Capital BDC during the second quarter worth about $165,000. Finally, NewEdge Advisors LLC increased its position in shares of Crescent Capital BDC by 20.2% during the fourth quarter. NewEdge Advisors LLC now owns 12,279 shares of the company’s stock worth $173,000 after purchasing an additional 2,066 shares in the last quarter. Hedge funds and other institutional investors own 49.46% of the company’s stock.

Crescent Capital BDC Company Profile

Crescent Capital BDC, Inc is a closed-end, externally managed business development company that provides flexible financing solutions to middle market companies in the United States. Trading on the Nasdaq under the ticker CCAP, the firm offers investors exposure to a diversified portfolio of debt and equity instruments, targeting businesses with attractive risk-adjusted return profiles. Its primary objective is to generate current income through interest payments and potential capital appreciation via selective equity co-investments.

The company’s investment strategy emphasizes senior secured loans, unsecured second-lien loans, mezzanine debt, as well as preferred and common equity co-investments.